Lung Cancer

Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing.

Ollila-Raj H, Murumägi A, Pellinen T, ..., Mäyränpää MI, Ilonen I

Lung Cancer 178 (-) 213-219 [2023-04-00; online 2023-03-01]

Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.

Moreno-Ruiz P, Corvigno S, Te Grootenhuis NC, ..., Micke P, Östman A

Lung Cancer 155 (-) 10-19 [2021-05-00; online 2021-02-25]

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.

Kerr KM, Bibeau F, Thunnissen E, ..., Malapelle U, Büttner R

Lung Cancer 154 (-) 161-175 [2021-04-00; online 2021-02-22]